» Articles » PMID: 18296502

Antiprion Properties of Prion Protein-derived Cell-penetrating Peptides

Overview
Journal FASEB J
Specialties Biology
Physiology
Date 2008 Feb 26
PMID 18296502
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

In prion diseases, the cellular prion protein (PrP(C)) becomes misfolded into the pathogenic scrapie isoform (PrP(Sc)) responsible for prion infectivity. We show here that peptides derived from the prion protein N terminus have potent antiprion effects. These peptides are composed of a hydrophobic sequence followed by a basic segment. They are known to have cell-penetrating ability like regular cell-penetrating peptides (CPPs), short peptides that can penetrate cellular membranes. Healthy (GT1-1) and scrapie-infected (ScGT1-1) mouse neuronal hypothalamic cells were treated with various CPPs, including the prion protein-derived CPPs. Lysates were analyzed for altered protein levels of PrP(C) or PrP(Sc). Treatment with the prion protein-derived CPPs mouse mPrP(1-28) or bovine bPrP(1-30) significantly reduced PrP(Sc) levels in prion-infected cells but had no effect on PrP(C) levels in noninfected cells. Further, presence of prion protein-derived CPPs significantly prolonged the time before infection was manifested when infecting GT1-1 cells with scrapie. Treatment with other CPPs (penetratin, transportan-10, or poly-L-arginine) or prion protein-derived peptides lacking CPP function (mPrP(23-28,) mPrP(19-30,) or mPrP(23-50)) had no effect on PrP(Sc) levels. The results suggest a mechanism by which the signal sequence guides the prion protein-derived CPP into a cellular compartment, where the basic segment binds specifically to PrP(Sc) and disables formation of prions.

Citing Articles

Designed Cell-Penetrating Peptide Constructs for Inhibition of Pathogenic Protein Self-Assembly.

Kalmouni M, Oh Y, Alata W, Magzoub M Pharmaceutics. 2024; 16(11).

PMID: 39598566 PMC: 11597747. DOI: 10.3390/pharmaceutics16111443.


C- and N-labeling of amyloid-β and inhibitory peptides to study their interaction via nanoscale infrared spectroscopy.

Paul S, Jenistova A, Vosough F, Berntsson E, Morman C, Jarvet J Commun Chem. 2023; 6(1):163.

PMID: 37537303 PMC: 10400569. DOI: 10.1038/s42004-023-00955-w.


Effect of the Lipid Landscape on the Efficacy of Cell-Penetrating Peptides.

Zakany F, Mandity I, Varga Z, Panyi G, Nagy P, Kovacs T Cells. 2023; 12(13).

PMID: 37443733 PMC: 10340183. DOI: 10.3390/cells12131700.


Aggregation Limiting Cell-Penetrating Peptides Derived from Protein Signal Sequences.

Porosk L, Hark H, Bicev R, Gaidutsik I, Nebogatova J, Armolik E Int J Mol Sci. 2023; 24(5).

PMID: 36901707 PMC: 10002422. DOI: 10.3390/ijms24054277.


Cell-Penetrating Peptides with Unexpected Anti-Amyloid Properties.

Osterlund N, Warmlander S, Graslund A Pharmaceutics. 2022; 14(4).

PMID: 35456657 PMC: 9027922. DOI: 10.3390/pharmaceutics14040823.